anti dnmt3b (MedChemExpress)
94
Structured Review
MedChemExpress
anti dnmt3b
Anti Dnmt3b, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dnmt3b/Dnmt3b+Antibody/pm41966552-69-2-46
Average 94 stars, based on 2 article reviews
Anti Dnmt3b, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dnmt3b/Dnmt3b+Antibody/pm41966552-69-2-46
Average 94 stars, based on 2 article reviews
anti dnmt3b - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Incubation:Article Title: A biomimetic arsenic-based nanozyme enhances dual epigenetic regulation to improve the efficacy of immunotherapy for acute myeloid leukaemia. Article Snippet: Aberrant epigenetic modifications in acute myeloid leukaemia (AML) limit immunotherapeutic efficacy.. Arsenic ions are capable of undergoing valence transformation in organisms, exhibit favourable enzyme-mimetic activity, and thereby play a crucial role in enhancing dual epigenetic regulation.. Therefore, to achieve potent epigenetic regulation, in this study, a biomimetic arsenic-based nanozyme (As/ZIF-8@M) that exhibits leukaemia cell recognition and phagocytosis capabilities, as well as bone marrow homing effects, was engineered. Expressing:Article Title: A biomimetic arsenic-based nanozyme enhances dual epigenetic regulation to improve the efficacy of immunotherapy for acute myeloid leukaemia. Article Snippet: Aberrant epigenetic modifications in acute myeloid leukaemia (AML) limit immunotherapeutic efficacy.. Arsenic ions are capable of undergoing valence transformation in organisms, exhibit favourable enzyme-mimetic activity, and thereby play a crucial role in enhancing dual epigenetic regulation.. Therefore, to achieve potent epigenetic regulation, in this study, a biomimetic arsenic-based nanozyme (As/ZIF-8@M) that exhibits leukaemia cell recognition and phagocytosis capabilities, as well as bone marrow homing effects, was engineered. Software:Article Title: A biomimetic arsenic-based nanozyme enhances dual epigenetic regulation to improve the efficacy of immunotherapy for acute myeloid leukaemia. Article Snippet: Aberrant epigenetic modifications in acute myeloid leukaemia (AML) limit immunotherapeutic efficacy.. Arsenic ions are capable of undergoing valence transformation in organisms, exhibit favourable enzyme-mimetic activity, and thereby play a crucial role in enhancing dual epigenetic regulation.. Therefore, to achieve potent epigenetic regulation, in this study, a biomimetic arsenic-based nanozyme (As/ZIF-8@M) that exhibits leukaemia cell recognition and phagocytosis capabilities, as well as bone marrow homing effects, was engineered. |